Growth Hormone Stack · Protocol Guide
CJC-1295 / Ipamorelin: The Complete Guide You Have Been Looking For
No marketing hype. No protocol myths. No units-vs-mcg confusion. Just the most transparent clinical guide we could write.
FDA Status
Off-Label, 503A Compounded
Pharmacy
Optimal Balance Pharmacy (503A licensed)
Medical Service
RxPepsDirect, physician-supervised
Access
33 U.S. States
Our promise: This guide cites evidence levels honestly. Where the data is weak or absent, we say so. CJC-1295 / Ipamorelin has decades of secondary clinical use but few large randomized trials. We treat the limits of that evidence as a feature, not a bug.
Medically reviewed by Dr. Jonathan Snipes, MD. Last reviewed May 18, 2026.Section 01
What It Actually Is
CJC-1295 / Ipamorelin is a combination of two peptides that work synergistically to stimulate your body natural growth hormone (GH) production. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that extends the GH release window. Ipamorelin is a selective growth hormone secretagogue that triggers a clean GH pulse without spiking cortisol or prolactin.
Together they amplify and sustain the pulsatile release of GH from the anterior pituitary, mimicking the body's natural rhythm rather than replacing it.
~30 min
Ipamorelin half-life
2 to 4x
GH pulse amplification
90 days
Minimum recommended protocol
Section 02
Who It Is Actually For
The most common patient profiles fall into four categories. A physician will evaluate your specific health history before prescribing.
| Feature | CJC-1295 (no DAC) | CJC-1295 DAC | Ipamorelin | Combined Stack |
|---|---|---|---|---|
| Half-life | ~30 min | ~8 days | ~30 min | Synergistic |
| Injection Frequency | 1 to 2 times daily | 1 to 2 times weekly | 1 to 2 times daily | 1 time daily |
| GH Pulse Quality | Pulsatile | Sustained | Clean | Excellent |
| Side Effects | Minimal | GH bleed risk | Minimal | Minimal |
| Most Common Use | Clinical | Convenience | Clinical | Gold standard |
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
Feature
CJC-1295 (no DAC)
CJC-1295 DAC
Ipamorelin
Combined Stack
| Patient Profile | Primary Goal | Typical Age | Fit |
|---|---|---|---|
| Age-related GH decline | Body composition, energy, and sleep | 35 to 60 | Excellent |
| Athletic recovery | Faster tissue repair and deeper sleep | 28 to 50 | Good |
| Metabolic optimization | Fat loss and insulin sensitivity | 30 to 55 | Good |
| Post-menopausal women | Body composition and bone density support | 45 to 65 | Underserved |
Patient Profile
Primary Goal
Typical Age
Fit
Patient Profile
Primary Goal
Typical Age
Fit
Patient Profile
Primary Goal
Typical Age
Fit
Patient Profile
Primary Goal
Typical Age
Fit
Section 03
How It Works
The key to understanding this stack is the concept of pulsatility. Your body does not release growth hormone in a steady stream. It releases GH in discrete pulses, primarily during deep sleep. This stack amplifies those natural pulses rather than creating an artificial, constant GH elevation.
Section 04
Realistic Expectations
One of the biggest sources of frustration with peptide therapy is unrealistic timelines. Here is what the clinical literature and patient reports actually suggest:
Improved Sleep Quality
Improved sleep is the most commonly reported early effect. Some patients notice deeper, more restorative sleep within the first few nights. Mild injection-site reactions (redness, warmth) are normal and typically resolve within 20 minutes.
Energy and Recovery
Increased energy and recovery speed. Some patients report better workout recovery and general vitality. Body composition changes are not yet visible. Injection-site flushing, if present, typically resolves by this point.
Skin and Cognition
Noticeable improvements in skin elasticity and hydration. Early body composition shifts: patients often report clothes fitting differently before the scale changes. Cognitive clarity improvements are commonly reported.
Measurable Body Composition Change
Measurable body composition changes: reduced visceral fat, improved lean mass. This is the minimum duration most physicians recommend before evaluating efficacy. Sleep architecture improvements are well-established by this point.
Full Protocol Benefits
Patients who have adhered to the protocol consistently report the most significant changes. Your physician will evaluate whether to continue, adjust dosing, or transition to a maintenance protocol.
Section 05
Dosing Protocol
The most common source of confusion (and error) in peptide therapy is the units-to-mcg translation. Here is the standard protocol RxPepsDirect physicians prescribe and Optimal Balance Pharmacy fills, broken down clearly.
Month 1: Titration
Draw to the 10-unit mark on a U-100 insulin syringe
10 units = 0.1 mL = 100 mcg each
100 mcg CJC-1295 + 100 mcg Ipamorelin per injection. One injection nightly, 5 nights per week.
Month 2+: Full Dose
Draw to the 20-unit mark on a U-100 insulin syringe
20 units = 0.2 mL = 200 mcg each
200 mcg CJC-1295 + 200 mcg Ipamorelin per injection. One injection nightly, 5 nights per week.
| Parameter | Month 1 | Month 2+ |
|---|---|---|
| Dose per peptide | 100 mcg | 200 mcg |
| Syringe draw | 10 units (0.1 mL) | 20 units (0.2 mL) |
| Frequency | 5 nights per week | 5 nights per week |
| Timing | 30 min before bed | 30 min before bed |
| Injection site | Subcutaneous (abdomen) | Subcutaneous (abdomen) |
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
Parameter
Month 1
Month 2+
Section 06
Cycling: Evidence vs. Myth
"Do I need to cycle CJC / Ipamorelin?" is one of the most common questions. Here is what the evidence actually says:
| Claim | Source | Evidence Level |
|---|---|---|
| Must cycle 8 weeks on, 4 weeks off | Forum consensus | No human RCT |
| 5-on / 2-off prevents desensitization | Clinical practice | Theoretical |
| Continuous use causes receptor downregulation | GHRP-6 extrapolation | Indirect |
| No cycling needed for no-DAC CJC-1295 | Pharmacokinetic rationale | Plausible |
| Annual cycling (3 months on, 1 month off) | Physician preference | Common practice |
Claim
Source
Evidence Level
Claim
Source
Evidence Level
Claim
Source
Evidence Level
Claim
Source
Evidence Level
Claim
Source
Evidence Level
Section 07
Ready to Inject
0
Reconstitution steps required
503A
Licensed pharmacy (Optimal Balance), physician-supervised
Overnight
FedEx shipping in a reusable cooled travel case
Section 08
Getting the Most From Your Protocol
The peptide itself is only part of the equation. These evidence-informed habits can meaningfully impact your results.
Timing
Bedtime Alignment
Inject 30 min before sleep
GH is released primarily during deep sleep (stages 3 and 4). Injecting 30 minutes before bed aligns the peptide-induced GH pulse with your body's natural nocturnal secretion window.
Nutrition
Fasted Injection Window
2 or more hours after last meal
Insulin blunts GH release. Eating, especially carbohydrates, within 2 hours of injection can significantly reduce the GH response. Inject on an empty stomach or at least 2 hours post-meal.
Avoidance
GH Suppressors
No alcohol or high-glycemic food
Alcohol and high-glycemic foods are potent GH suppressors. Even moderate alcohol consumption on injection nights can reduce your GH pulse by 50 to 75 percent.
Schedule
5-On / 2-Off Rationale
Receptor sensitivity preservation
The 2-day break each week is theorized to prevent GH receptor desensitization, though direct human evidence is limited. It also provides practical relief from the daily injection routine.
Recovery
Sleep Architecture
Prioritize sleep hygiene
If your sleep environment is poor, you are undermining the primary mechanism of action. Consistent sleep schedule, dark room, cool temperature, and limited screen time before bed all amplify protocol effectiveness.
Mindset
The 90-Day Rule
Minimum commitment period
Body composition changes require time. Most physicians recommend a minimum 90-day commitment before evaluating efficacy. Patients who discontinue at 4 to 6 weeks often miss the window where measurable changes begin.
Section 09
Stacking
Stacking refers to combining CJC-1295 / Ipamorelin with other peptides or compounds. Some combinations are well-supported, others carry meaningful risk.
Pairs Well With
BPC-157
Tissue repair and gut healing. Complementary mechanism, no known interaction.
Thymosin Beta-4 (TB-500)
Systemic tissue repair. Often paired in recovery-focused protocols.
MOTS-c
Mitochondrial peptide. Targets metabolic function via a different pathway.
NAD+ therapy
Cellular energy. Different mechanism entirely. No competitive interaction.
Approach With Caution
MK-677 (Ibutamoren)
Oral GH secretagogue. Can cause sustained GH elevation and insulin resistance when combined with CJC / Ipa.
GHRP-6 / GHRP-2
Redundant mechanism with more side effects. Cortisol and prolactin spikes.
Exogenous HGH
Combining with GH secretagogues can cause supraphysiologic GH levels. Physician assessment required.
Multiple GH-axis compounds
Stacking 3+ GH-targeting compounds increases unpredictability without proportional benefit.
Section 10
Pricing
| Option | Medication Cost | Medical Cost | Notes |
|---|---|---|---|
| Other Online Clinics | $250 to $450 per month | Visit fees often bundled and not disclosed publicly | Per-cycle pricing varies. Verify all-in cost before committing. |
| Optimal Balance Pharmacy + RxPepsDirect | $100 per 10 mg + 10 mg vial, paid to pharmacy | $39 visit fee, paid to RxPepsDirect | Pre-reconstituted, FedEx overnight, labeled to you. RxPepsDirect provides medical oversight only. The pharmacy ships the medication. |
| Gray Market (Research Vendor) | $40 to $80 per month | None (no prescription) | Research-grade. No physician, no monitoring, no labeled prescription, no quality verification. |
Option
Medication Cost
Medical Cost
Notes
Option
Medication Cost
Medical Cost
Notes
Option
Medication Cost
Medical Cost
Notes
Who You Pay, and What For
Pharmacy: Medication
$100 per 10 mg + 10 mg vial. Compounded and shipped by Optimal Balance Pharmacy, a 503A licensed compounding pharmacy. You pay the pharmacy directly. RxPepsDirect does not handle medication payments.
Medical Service: Physician Consultation
$39 medical visit fee. Intake consultation, protocol design, prescription writing, and follow-up check-ins. Billed by RxPepsDirect for the medical service only. Async messaging included.
Section 11
Legal Access in 33 States
503A Licensed Pharmacy
Optimal Balance Pharmacy, U.S. licensed compounding
Physician Prescription Required
Compounded medication, Rx only
Off-Label, Legal Practice
Standard and legal in U.S. medicine
Reclassification Pending
FDA peptide review ongoing as of 2026
CJC-1295 and Ipamorelin are currently available through the 503A patient-specific compounding pathway. State-licensed pharmacies like Optimal Balance compound medications under federal Section 503A oversight, which exempts them from the standard new-drug approval requirements when filling a patient-specific prescription written by a licensed prescriber.
In 2023 the FDA began reviewing certain peptides for potential reclassification. As of this writing, CJC-1295 and Ipamorelin remain available through the 503A pathway. The regulatory environment is actively evolving. RxPepsDirect monitors these changes in real time and will communicate any impacts to active patients.
Off-label prescribing is a standard, legal practice in U.S. medicine. Approximately one in five prescriptions written in the United States is off-label. Your physician will explain the regulatory status and evidence base for your specific protocol during your consultation.
Section 12
Community Q&A
I had flushing and warmth after injection. Is that normal?
Yes. Injection-site flushing is one of the most common early side effects and typically resolves within 10 to 20 minutes. It is caused by local vasodilation triggered by the GH pulse. Most patients report it disappears entirely by week 3 or 4. If it persists or worsens, contact your physician.
I gained weight in the first 2 weeks. Is this working?
Early weight gain is almost always water retention, not fat gain. GH promotes intracellular hydration. This typically stabilizes by week 3 or 4. Body composition changes (fat loss, lean mass increase) will not be visible until week 8 to 12. Judge by how clothes fit, not the scale.
I feel hungry after my injection. Is that the peptide?
Ipamorelin has minimal ghrelin-receptor activity compared to GHRP-6, but some patients do report mild hunger post-injection. This is not a universal effect. If it is disruptive, discuss timing adjustments with your physician.
Can I have a small snack before my injection?
A small protein-based snack 2 or more hours before injection is fine. Avoid carbohydrates and sugar within 2 hours of injection, since insulin release blunts the GH response. The ideal protocol is injecting on an empty stomach 30 minutes before bed.
Is CJC-1295 / Ipamorelin the same as HGH?
No. HGH (somatropin) is synthetic growth hormone injected directly, while CJC / Ipamorelin stimulates your pituitary to produce its own GH. The key differences: CJC / Ipa preserves pulsatile release, has fewer side effects, does not suppress natural production, and does not carry the same regulatory restrictions as HGH.
Why does RxPepsDirect not require labs to start?
Labs are valuable but can be a barrier to access. They are not required to start because: (1) the safety profile of CJC / Ipa at standard doses is well-characterized, (2) physician intake screening catches most contraindications, and (3) labs at 90 days are typically recommended to assess response. Your prescribing physician may recommend baseline labs based on your health history.
What happens if Optimal Balance Pharmacy is out of stock?
Pharmacy supply chains can fluctuate. If Optimal Balance is temporarily unable to fill your prescription, your RxPepsDirect physician will be notified and you will be contacted before any delay impacts your protocol. You only pay the pharmacy when your prescription actually ships.
Section 13
The RxPepsDirect Model
Everything above describes why trust matters in peptide therapy. The bridge model is built to earn that trust by separating medical judgment from medication sales.
Pharmacy: Optimal Balance, 503A Licensed
Optimal Balance Pharmacy compounds your CJC / Ipamorelin under a patient-specific prescription, USP <797> sterile standards, and federal 503A oversight. The pharmacy ships the medication directly to you and bills you for the medication.
Medical Service: RxPepsDirect Physicians
A licensed physician reviews your history, designs your protocol, writes your prescription, and is available for check-ins. RxPepsDirect bills the $39 medical visit fee for this service. That fee does not include medication.
Transparent Safety Communication
The guide above flags the evidence gap, the DAC-vs-no-DAC trap, the cycling-myth landscape, and the gray-market purity problem. We do not hide limitations to make a sale, because we do not profit from medication sales.
Legal Access in 33 States
Every shipment is a compounded prescription medication filled by a 503A licensed pharmacy under a physician prescription. The 503A pathway with physician prescription is the documented legal route for compounded peptide therapy in the United States.
References
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID: 9849822
- Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PMID: 16352683
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006. PMID: 17018654
- Sun Y, Wang P, Zheng H, et al. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A. 2004. PMID: 15070777
- Sinha DK, Balasubramanian A, Tatem AJ, et al. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020. PMID: 32257855
Related protocol guides
Other protocols in the same clinical territory. Each guide is co-bylined by a licensed RxPepsDirect prescriber.
GHRH analog (GRF 1-29)
Sermorelin protocol guide: pharmacology, dosing, IGF-1 monitoring, and the non-responder reality
The only GHRH analog still Category 1 compoundable. Daily injection, 6 to 12 month protocol, 30 to 40 percent non-responder rate, and IGF-1 the biomarker that decides the answer.
GHRH analog (FDA-approved as Egrifta)
Tesamorelin protocol guide: visceral fat reduction, dosing, and Phase III evidence
The only GHRH analog with Phase III trials and an FDA approval. Visceral fat reduction, the 31 percent non-responder rate, and what reaccumulates when you stop.
Oral GH secretagogue (MK-677)
Ibutamoren (MK-677) guide: oral ghrelin receptor agonist, water retention, glucose elevation, WADA prohibition
The only oral GH secretagogue. Real GH and IGF-1 elevation. Real water retention. Real fasting-glucose drift. WADA prohibited. Monitoring is mandatory.